High Power Photodynamic System Hair Regrowth PDT Skin Whitening LED Therapy
Principle of LLLT Engineering Science
LUMENCARE Low Level Laser Therapy (LLLT) is the exposure and interaction of light, delivered through Light Emitting Diodes (LEDs), to regulate cellular functions, which is helpful in the treatments of wound healing, pain relief, anti- inflammation and skin rejuvenation etc. HEALITE II applies 830nm, 633nm and 415nm lights to deliver and focuse high energy on skin, offering expectant results without physical trauma or thermal injury. LUMENCARE therapy can be used alone or combined with other therapies.
Optical Lens Array Technology (OLAT) employs collimation optics technology, which can control and transmit the therapeutic energy of 4800 new-generation leds more effectively, so as to collect high-intensity therapeutic photons to target tissues and cells, and maximize the clinical effect.
Wound healing
Pain relief
Muscle and joint pain relief
Muscle spasm
Temporary increase in blood
circulation
Hair regrowth
Inflammatory acne
Skin rejuvenation
Non-melanoma skin cancer
(PDT plus 5-ALA therapy)
Skin rejuvenation
Hair Regrowth
Inflammatory acne
Why Apply LED For LLLT Therapy?
Ideal wavelength
Energy penetrates any treatment depths
Effective in subcellular, cellular and tissue level
Treatment alone or as a supplementary tre atment
Treatment of multiple indications
Painless, non-invasive, and suitable for patients of any age
Why Choose LUMENCARE
Photon Sequencing Technique (PST)
Optical Lens Array Technology (OLAT)
Total 4800pcs durable and high quality LEDs
Adjustable irradiation panel and arm
Ergonomic design
User-friendly color touch screen
Easy and stable operation
Applications---as a supplementary therapy
Wound healing acceleration after laser and surgical treatment
Pain relief, bruises, edema and erythema reduction
Prevention of scars
PIH reduction
Further improvement of clinical effect
Before and after
|
Comparison of healing time |
||
|
Applications |
LUMENCARE untreated |
LUMENCARE treated |
|
Facelift |
up to 13 weeks |
up to 6 weeks (decrease 53%) |
|
Bruise |
1 week |
1 or 2 days (decrease 78%) |
|
Erythema |
15 or 16 weeks |
2 weeks (decrease 87%) |
|
Edema |
5 days or 1 week |
2 or 3 days (decrease 58%) |
